2020 Teal Turkey Trot
Trot before you turkey for ovarian cancer research!
Looking for a fun activity to do with your family, friends, quaranteam, or pod... either together physically or virtually?! Look no further! We're certain that research somewhere shows that being grateful while you move your body for cancer research kicks off Thanksgiving on the right foot!
Register for STAAR's 1st Annual Teal Turkey Trot 5K Run/Walk/Skip/Cycle! Whatever means you want to use to move your body, we accept it! Indoors on your Peloton? Cool. Outdoors around your neighborhood? Great too. Pushing a stroller? Yep. You walking and your child scooting along? Of course! You want to register your dog? Truly... the more, the merrier! Can't make it 5K? No problem! Just get out and have some fun!!
Registration fee is $30 for adults and $10 for kids and includes a free STAAR-branded neck gaiter/headband/whatever you want to make it (must register by 11/10 to guarantee swag arrival)*
.jpg)
Create a team, join a team, or register as an individual... whatever strikes your fancy!
About STAAR Ovarian Cancer Foundation:
STAAR was co-founded by three low-grade ovarian cancer thrivers in early 2020. The foundation exists to fund research for better treatment options for low-grade serous carcinoma, a rare (fewer than 10% of ovarian cancer cases) and extremely underfunded subtype. Low-grade serous carcinoma is often labeled as a "tricky opponent" by clinicians because it acts differently than more common subtypes - it grows slower and is often chemo-resistant. The average age of diagnosis is 18 years younger than ovarian cancer overall, meaning that many diagnosed are young moms or never got a chance to have children.
Ovarian cancer is the fifth leading cause of cancer death in women - it's the deadliest of all gynecologic cancers. Each year, 22K American women will be diagnosed and 14K will die. The five-year survival rate hangs at 48%... half of that of breast cancer. With no early detection test and symptoms that often lead to misdiagnoses, 60% of women are diagnosed in stage 3. As a rare cancer (1 in 78 women vs. 1 in 8 women for breast cancer), funding simply isn't plentiful. Research is imperative to improve the lives of those living with the disease and to find methods of early detection.
For more information on ovarian cancer, visit OCRA. For additional details on low-grade serous carcinoma, visit Cure Our Ovarian Cancer
